{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:08:31Z","timestamp":1773266911068,"version":"3.50.1"},"reference-count":78,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T00:00:00Z","timestamp":1089849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p>In premenopausal women ovaries are the major sites of estrogen production, while in postmenopausal women estrogen is produced by aromatization of ovarian and adrenal androgens in extragonadal sites, mostly in adipose tissue. Aromatase is a cytochrome\u2003P450 hemoprotein\u2010containing enzyme complex that catalyzes the rate\u2010limiting step in the conversion of androstenedione and testosterone to estrone and estradiol (E2). Aromatase inhibitors (AIs) have been developed primarily for use in either natural or surgical postmenopausal patients. In premenopausal women, the ovary can overcome the estrogen blockade by reflex increments of luteinizing hormone (LH) and follicle stimulating hormone (FSH), so AIs must be combined with a gonadotropin releasing hormone (GnRH) agonist to prevent the reflex LH and FSH increments. In advanced hormone\u2010dependent breast cancer treatment, AIs have been shown to be superior to tamoxifen. Preliminary evidence also suggests superiority in the adjuvant, neoadjuvant settings and also for breast cancer prevention. AIs have been used in infertility and can increase ovulation rate. Reducing FSH dose, estrogen levels, improving response to FSH, implantation rates, and developing multiple follicles that can be used in <jats:italic>in\u2003vitro<\/jats:italic> maturation procedures are potential areas that AIs might be used in in assisted reproductive technologies (ART), besides simple ovulation induction. AIs are reported to be successful in treatment of endometriosis, an estrogen\u2010dependent process. The use of AIs in gynecomastia, puberte precox, leiomyoma uteri, some estrogen\u2010dependent cancers (ovarian), endometrial cancer and male infertility are reported; some of the results are promising but more clinical trials are needed. AIs are predicted to become the gold standard in the treatment of estrogen\u2010dependent diseases in reproductive medicine in the near future.<\/jats:p>","DOI":"10.1111\/j.0001-6349.2004.00562.x","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T13:22:16Z","timestamp":1089897736000},"page":"699-706","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Aromatase inhibitors: possible future applications"],"prefix":"10.1111","volume":"83","author":[{"given":"\u00d6znur","family":"Karaer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Semra","family":"Oru\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faik M\u00fcmtaz","family":"Koyuncu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,7,15]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.7.3007"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb03794.x"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2002.810706.x"},{"key":"e_1_2_11_5_2","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1210\/endo.142.11.8547","article-title":"Minireview: aromatase and the regulation of estrogen biosynthesis\u2014some new perspectives","volume":"142","author":"Simpson ER","year":"2001","journal-title":"Endocrinology"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(98)00007-5"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1210\/rp.57.1.317"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(78)90287-9"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/02841869609083966"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-1-7-465"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-5-12-2005"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-116-1-38"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.2.428"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1210\/mend-5-12-2005"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-117-6-2471"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-63-3-717"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0039-128X(83)90078-8"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(98)00069-0"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021559"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.117432"},{"key":"e_1_2_11_21_2","first-page":"337","article-title":"Detection of intramural aromatase in breast carcinomas. An immunohistochemical study with clinicopathologic correlation","volume":"140","author":"Esteban J","year":"1992","journal-title":"Am J Pathol"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1210\/en.141.10.3852"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.80.6.1941"},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.2.649"},{"key":"e_1_2_11_25_2","first-page":"139","volume-title":"Understanding and Managing Endometriosis. Advances in Research and Practice","author":"Bulun SE","year":"1998"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(01)00134-0"},{"key":"e_1_2_11_27_2","doi-asserted-by":"crossref","first-page":"5364","DOI":"10.1016\/S0021-9258(20)79735-8","article-title":"Utilization of oxygen and reduced nicotinamide adeninedinucleotide phosphate by human placental microsomes during aromatization of androstenedione","volume":"249","author":"Thompson EA","year":"1974","journal-title":"J Biol Chem"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-47-6-1257"},{"key":"e_1_2_11_29_2","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1001\/jama.1974.03240120029015","article-title":"Successful medical adrenalectomy using aminoglutethimide: a role of altered drug metabolism","volume":"230","author":"Santen RJ","year":"1974","journal-title":"J Am Med Assoc"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197402)33:2<503::AID-CNCR2820330227>3.0.CO;2-L"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-55-4-718"},{"key":"e_1_2_11_32_2","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s101470200040","article-title":"The evolving role of aromatase inhibitors in breast cancer","volume":"7","author":"Mokbel K","year":"2002","journal-title":"Int J Clin Oncol"},{"key":"e_1_2_11_33_2","first-page":"75","volume-title":"Endocrine Therapy of Breast Cancer","author":"Yue W","year":"2002"},{"key":"e_1_2_11_34_2","first-page":"4823","article-title":"Treatment of advanced postmenopausal breast cancer with the aromatase inhibitor, 4\u2010hydroxyandrostenedione: Phase II report","volume":"46","author":"Goss PE","year":"1986","journal-title":"Cancer Res"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(03)00096-5"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0960-0760(90)90460-3"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(84)92795-8"},{"key":"e_1_2_11_38_2","first-page":"10","article-title":"Aromatase inhibitors and breast cancer","volume":"23","author":"Broodie AM","year":"1996","journal-title":"Semin Oncol"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.10.2596"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0959-8049(01)00155-1"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<100::AID-CNCR14>3.0.CO;2-5"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11124"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1185\/030079902125000066"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00666067"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-51-3-473"},{"key":"e_1_2_11_46_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1005937900788"},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1020361700012"},{"key":"e_1_2_11_48_2","first-page":"2109","article-title":"Inhibition of breast cancer tissue aromatase activity and estrogen concentrations by the third\u2010generation aromatase inhibitor vorozole","volume":"57","author":"DeJong PC","year":"1997","journal-title":"Cancer Res"},{"key":"e_1_2_11_49_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0060187"},{"key":"e_1_2_11_50_2","first-page":"211","article-title":"Final survival analysis of the double\u2010blind, randomized, multinational phase III trial of letrozole (Femara) compared to tamoxifen as first\u2010line hormonal therapy for advanced breast cancer","volume":"69","author":"Mouridsen H","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_2_11_51_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20011101)92:9<2247::AID-CNCR1570>3.0.CO;2-Y"},{"key":"e_1_2_11_52_2","first-page":"210","article-title":"The ATAC (Arimidex, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial in post\u2010menopausal women","volume":"69","author":"Baum M","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.18.3808"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(00)01705-2"},{"key":"e_1_2_11_55_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(01)03280-0"},{"key":"e_1_2_11_56_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-200206000-00003"},{"key":"e_1_2_11_57_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2003.00144.x"},{"key":"e_1_2_11_58_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo-119-3-1403"},{"key":"e_1_2_11_59_2","doi-asserted-by":"publisher","DOI":"10.1677\/joe.0.0840409"},{"key":"e_1_2_11_60_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2002.tb02767.x"},{"key":"e_1_2_11_61_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.7.3460"},{"key":"e_1_2_11_62_2","first-page":"261","volume-title":"Understanding and Managing Endometriosis. Advances in Research and Practice","author":"Vercellini P","year":"1998"},{"key":"e_1_2_11_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)03233-8"},{"key":"e_1_2_11_64_2","first-page":"192","article-title":"Studies on the effect of new non\u2010steroidal aromatase inhibitor fadrozole hydrochloride in an endometriosis model in rats","volume":"46","author":"Yano S","year":"1996","journal-title":"Arzneimittelforshung"},{"key":"e_1_2_11_65_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-0760(01)00134-0"},{"key":"e_1_2_11_66_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0412.2001.800708.x"},{"key":"e_1_2_11_67_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0060315"},{"key":"e_1_2_11_68_2","doi-asserted-by":"publisher","DOI":"10.1677\/erc.0.0060303"},{"key":"e_1_2_11_69_2","first-page":"945","article-title":"Effective aromatase inhibition by anastrozole in a patient with gonadotropin\u2010independent precocious puberty in McCune\u2013Albright syndrome","volume":"15","author":"Roth C","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"e_1_2_11_70_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-021780"},{"key":"e_1_2_11_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(02)04761-1"},{"key":"e_1_2_11_72_2","doi-asserted-by":"publisher","DOI":"10.3109\/00016348409156709"},{"key":"e_1_2_11_73_2","first-page":"2233","article-title":"CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine\u2010sensitive subgroup","volume":"8","author":"Bowman A","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_11_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(02)00147-1"},{"key":"e_1_2_11_75_2","doi-asserted-by":"publisher","DOI":"10.1385\/MO:20:1:87"},{"key":"e_1_2_11_76_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200262120-00004"},{"key":"e_1_2_11_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0094-0143(02)00085-X"},{"key":"e_1_2_11_78_2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmg002"},{"key":"e_1_2_11_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)69099-2"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-6349.2004.00562.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0001-6349.2004.00562.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0001-6349.2004.00562.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T14:09:03Z","timestamp":1697378943000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.0001-6349.2004.00562.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7,15]]},"references-count":78,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.0001-6349.2004.00562.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0001-6349.2004.00562.x","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7,15]]},"assertion":[{"value":"2004-07-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}